Search

A recent meta-analysis examined the Congruency Hypothesis, which suggests that women who change their hormonal contraceptive use after meeting their partner will have lower sexual satisfaction compared to women who do not change their oral contraceptive use. The analysis found that for studies using between-subjects designs, there was no statistically significant correlation between congruency and sexual satisfaction. However, for studies using within-subjects designs, there was a statistically significant correlation, although weak, in favor of the Congruency Hypothesis. Overall, the results suggest that changing oral contraceptive use is unlikely to have a substantial effect on women's sexual satisfaction with their partner. Further research, ideally in the form of randomized controlled trials, is needed to provide a definitive answer. [Extracted from the article]

A recent study conducted by researchers at San Diego State University explored the potential benefits of consuming prunes in mitigating the adverse effects of oral contraceptives (OCs) on bone health in young adult women. The study involved 90 women who were randomly assigned to different groups, including a control group not using OCs, an OC group not consuming prunes, and an OC group consuming 50g of prunes daily. The researchers found that consuming prunes tended to have a potential protective effect on trabecular density of the distal tibia and ultradistal radius, while OC use had minor negative effects on bone. The study suggests that prunes could be a safe and inexpensive solution to prevent bone loss associated with OC use. [Extracted from the article]

A study published in Current Developments in Nutrition suggests that eating a serving of prunes daily for a year may help reduce the risk of bone loss associated with oral contraception use in women aged 18 to 25. The study found that bone mineral density at the ultradistal radius increased significantly among women taking oral contraceptives and consuming 50 grams of prunes daily. The exact reasons for this effect are not fully understood, but it is believed that prunes inhibit bone resorption by reducing the activity of osteoclasts. Prunes are nutrient-rich and contain minerals, vitamin K, phenolic compounds, and fiber that are important for bone health. This study expands upon previous research on prunes' effects on bone health, which primarily focused on postmenopausal women. [Extracted from the article]

This document provides information about a clinical trial conducted by Peking University Cancer Hospital & Institute in China. The trial aims to evaluate the effectiveness of Liangxue ointment, a traditional Chinese medicine, in treating hand-foot syndrome (HFS) associated with VEGFR-TKI drugs in patients with malignant tumors. The trial involves applying the ointment twice a day for 14 days, with two courses of treatment. The study is currently recruiting participants, and the completion date is projected to be March 25, 2025. The eligibility criteria for participants are outlined, and the trial is open to both men and women. The document also includes administrative information such as the NCT number and the plan for sharing data. [Extracted from the article]

This article discusses the gynecological health patterns and motherhood experiences of female professional football players. The study found that cycle irregularities and menstrual symptoms were common among the participants, with 30% experiencing irregularities and 74% experiencing symptoms. Half of the participants used contraceptives, with the majority preferring hormonal contraceptives such as oral contraceptive pills and implants. The study also found that the rate of motherhood among female professional football players was low, and participants had a higher-than-expected drive for thinness. Overall, the findings suggest that gynecological health and reproductive choices among female professional football players may be influenced by their athletic careers. [Extracted from the article]

A recent study conducted by McMaster University in Toronto, Canada, examined the influence of natural menstrual (NAT) and oral contraceptive pill (OCP) cycles on vascular outcomes in premenopausal females. The study found that NAT and OCP phases had minimal influence on vascular function and associated cellular regulation, with the exception of a small effect on brachial artery endothelial function. The researchers concluded that the differences in baseline artery diameter may partially explain this effect. Overall, the study suggests that menstrual and oral contraceptive pill cycles have minimal impact on cardiovascular outcomes in premenopausal females. [Extracted from the article]

A preprint abstract from biorxiv.org discusses a study that investigated the effects of oral contraceptive use on the proteome profiles of African American women with untreated high blood pressure. The study analyzed the levels of 2,941 serum proteins in 51 pre-menopausal women, 13 of whom were oral contraceptive users and 38 were non-users. The results showed that oral contraceptive use was associated with alterations in the plasma proteome, with 31 proteins showing decreased levels and 13 proteins showing increased levels in users. Pathway and gene ontology analyses revealed potential links to cardiovascular disease. This study provides new insights into the proteomic landscape associated with oral contraceptive use among African American women with uncontrolled hypertension. [Extracted from the article]

A recent study conducted at the National University of Singapore Hospital explored the relationship between reproductive factors and the risk of physical frailty among Chinese women living in Singapore. The study found that younger ages at menarche (onset of menstruation) and menopause were associated with a higher likelihood of physical frailty in later life. However, factors such as duration of reproductive period, number of children, and use of oral contraceptives or hormone replacement therapy were not significantly associated with the risk of physical frailty. This population-based cohort study provides valuable insights into the impact of reproductive factors on women's health in Singapore. [Extracted from the article]

A recent report from the Quebec University Hospital Research Center discusses the medical management of endometriosis. The researchers highlight the importance of managing painful symptoms through hormonal and nonhormonal treatments. They summarize recent evidence on various medical management options, including the efficacy of different medications in relieving pain associated with endometriosis. The report suggests that suppressive treatment, such as the combined oral contraceptive pill and progestogens, can be offered to symptomatic women who are not seeking immediate fertility. It also mentions the increasing use of complementary and alternative medicines in managing endometriosis. [Extracted from the article]

A study conducted at the Federal University Santa Catarina in Florianopolis, Brazil, aimed to investigate the effects of oral contraceptive pill intake and menstrual phase on strength, muscle soreness, and recovery after an exercise protocol in trained women. The study involved 26 women, divided into two groups: contraceptive users and non-users. The results showed that perceptual responses to exercise differed between the menstrual and non-menstrual phase, but did not depend on oral contraceptive use. This research provides new insights into the relationship between female contraceptive agents and muscular performance in trained women. [Extracted from the article]

A clinical trial, NCT06546397, is currently recruiting participants to study the effects of combined estrogen and progesterone therapy on endometrial repair and ovarian function recovery after induced abortion. The trial aims to address potential risks associated with repeated induced abortions, such as uterine damage and infertility. The study will evaluate the thickness of the endometrium, cycle normalization rate, duration of vaginal bleeding after surgery, and menstrual flow volume as primary and secondary outcome measures. The study is being conducted in China and is expected to be completed by December 2025. [Extracted from the article]

A study conducted by researchers at the Polytechnic University of Madrid explored how fluctuations in sex hormones may affect bone metabolism in response to running. The study analyzed the concentrations of certain hormones and bone markers in eumenorrheic females and oral contraceptive users during different phases of their menstrual cycle. The findings showed that sex hormone concentrations have an impact on bone metabolism during exercise, with higher post-exercise bone marker concentrations observed in all menstrual cycle phases compared to the active pill-taking phase of the oral contraceptive cycle. This research highlights the importance of studying exercising females with different hormonal profiles to better understand the effects on bone health. [Extracted from the article]

A research study conducted by the Berlin Center for Epidemiology and Health Research (ZEG) compared the safety and effectiveness of two types of female contraceptive agents, NOMAC-E2 and levonorgestrel-containing COCs (COCLNG), in women over the age of 40. The study, which included participants from Europe, Australia, and Latin America, found that NOMAC-E2 did not increase the risk of venous thromboembolism (VTE) compared to COCLNG. Additionally, unintended pregnancy rates were similar between the two groups, and there were no significant differences in mood and weight changes. The researchers concluded that NOMAC-E2 can be considered a valid alternative to COCLNG for perimenopausal women. [Extracted from the article]

A new study conducted by the Berlin Center for Epidemiology and Health Research (ZEG) has found that NOMAC-E2, a type of female contraceptive agent, is more effective at preventing unintended pregnancies in women under 25 compared to levonorgestrel-containing combined oral contraceptives (COCLNG). The study, which followed over 12,000 NOMAC-E2 users and 17,000 COCLNG users, found that the risk of unintended pregnancy was significantly lower in the NOMAC-E2 group. Additionally, the study found no significant differences in acne, mood, and weight changes between the two groups. This research provides valuable insights into contraceptive options for young women. [Extracted from the article]

A report from the University of Pavia in Italy discusses the underutilization of oral contraceptives by Italian women compared to other European women. The researchers highlight the mandatory medical prescription as a significant barrier to accessing oral contraceptives in Italy. They suggest reclassifying oral contraceptives and expanding pharmacy services to increase the use of safe and effective contraceptive methods. The report emphasizes the potential benefits of streamlining access to oral contraception, including improved emotional well-being for women and potential cost savings for the healthcare system. [Extracted from the article]

A study conducted by researchers at the Kirk Kerkorian School of Medicine at UNLV analyzed 1,000 TikTok videos related to oral contraceptives. The study found that the majority of videos contained low-quality and unreliable information, with non-healthcare providers being the main creators. Healthcare professionals who did create videos with reliable information received less engagement than non-healthcare professionals. The study suggests that healthcare providers should be aware of the prevalence of poor-quality information on social media when counseling patients about reproductive health. [Extracted from the article]

A recent study conducted by the University of Chicago Medicine explores the management of amenorrhea (absence of menstruation) in pre-menopausal women with hematologic cancer. The study highlights the additional challenges faced by these women due to menstrual bleeding and cytopenias associated with the disease and its treatment. The researchers conducted a thorough literature review and combined it with clinical expertise to propose a systematic approach for menses prophylaxis and suppression. The study recommends the use of GnRH agonists as the preferred therapy for achieving menses control and amenorrhea, with the addition of oral contraceptives or estrogen therapy as secondary agents. The protocol aims to provide standardization among clinicians and adaptability for patient-specific needs. [Extracted from the article]

A study conducted by researchers at Delta State University investigated the potential of the alkaloid extract of Moringa oleifera leaf (AML) as a tocolytic agent, which is a substance that prevents preterm births by reducing or stopping uterine contractions. The study utilized both in vitro and in silico methods to analyze the effects of AML. The results showed that AML and its active fraction, chloroform fraction of AML (CAML), significantly inhibited spontaneous contractions and had compounds that could interact with receptors and proteins associated with uterine contractions. This suggests that AML and CAML have the potential to be effective tocolytic agents. [Extracted from the article]

This document provides information about a clinical trial investigating the use of Interferon gamma-1b (IFN-g) and Donor Leukocyte Infusion (DLI) as a treatment for relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after an allogeneic stem cell transplant (alloSCT). The trial aims to determine the efficacy of this treatment and explore its potential use in other contexts, such as relapsed disease after haploidentical alloSCT and prevention of relapse in patients who can only tolerate reduced-intensity conditioning regimens. The trial is not yet recruiting participants and is expected to be completed by August 2027. The study is being conducted in the United States and is sponsored by the University of Pittsburgh. [Extracted from the article]

A clinical trial, NCT06509503, is currently recruiting participants in Egypt to study the impact of combined oral contraceptive pills (COCs) on migraines. The trial aims to understand how hormonal contraceptive use affects individuals with migraines. The study will involve two groups, one using COCs and the other using non-hormonal contraception, and will evaluate the number of migraine days, reduction in headache frequency, safety of treatment, and other features of migraines. The trial will last for three months and aims to include 400 female migraine patients aged 18-55 years. [Extracted from the article]

A recent review article from Wollongong Hospital in Australia explores the potential interaction between sugammadex, a drug used in anesthesia, and hormonal contraceptives. The review examines recent clinical data and concludes that the interaction between sugammadex and estrogen and progesterone concentrations may not be clinically significant and may even provide some protection against ovulation. However, there is a lack of strong clinical evidence to support or refute claims of a significant impact of sugammadex on contraceptive efficacy. The research suggests that there is no basis for concern regarding the impact of sugammadex on contraception in the perioperative setting. [Extracted from the article]

A study conducted at Sana'a University in Yemen examined the effects of oral contraceptive (OC) use and khat chewing on telomerase levels and tumor suppressor genes in breast cancer patients and normal volunteers. The study involved 140 Yemeni women aged 25-40, including 60 newly diagnosed breast cancer patients and 80 control subjects. The results showed that breast cancer patients had significantly higher levels of telomerase, p53, and p21 compared to the control group. The use of OCs increased telomerase in the control group but had no effect in breast cancer patients, while khat chewing increased p53 in both groups and p21 in breast cancer patients. The combined use of OCs and khat chewing increased telomerase and p53 in the control group and increased p53 and p21 in breast cancer patients. Telomerase was identified as a risk factor for breast cancer, while khat chewing was found to be protective. The study suggests that the combined use of OCs and khat chewing reduces the risk factor of telomerase. [Extracted from the article]

A recent report from the Razi Clinical Research Development Unit discusses the case of a 41-year-old woman with a giant pedunculated hepatic hemangioma, a rare type of benign liver tumor. The woman had been taking oral contraceptives for 10 years and presented with symptoms such as discomfort in the upper quadrant and early satiety. Imaging revealed a solid mass in the liver, and due to the risk of complications, surgical excision was performed. The report emphasizes the importance of imaging to diagnose these tumors and the need for surgery to prevent acute problems like torsion and rupture. [Extracted from the article]

A new report from Hubei University of Medicine in China explores the association between oral contraceptives and cervical cancer. The study, which used data from the National Health and Nutrition Examination Survey, found that contraceptive use was positively associated with an increased risk of cervical cancer. The research also identified specific factors, such as age, BMI, smoking status, and number of sexual partners, that may contribute to the development of cervical cancer. These findings suggest a need for further investigation into the potential risks of oral contraceptives in relation to cervical cancer. [Extracted from the article]

A study conducted by Fudan University in Shanghai, China analyzed the use of tocolytic agents in preterm labor from 2016 to 2021. Tocolytic agents are used to prolong gestational age and prevent immediate preterm birth. The study found that the total number of tocolytic prescriptions and the total cost of tocolytic agents increased over the six-year duration of the study. The top three tocolytic agents used were magnesium sulfate, ritodrine, and nifedipine. The study also identified inappropriate prescriptions and the need for efforts to ensure the safety and appropriateness of maternal medication. [Extracted from the article]

A recent study conducted by Ibis Reproductive Health explored the interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States. The study found that 45% of the participants were interested in accessing these contraceptive pills without a prescription. Factors such as age, insurance status, current use of oral contraceptives, education level, sterilization, and use of testosterone for gender affirmation influenced the level of interest. The availability of over-the-counter progestin-only pills has the potential to improve contraceptive access for this population. [Extracted from the article]

A study conducted by researchers from the University of North Carolina examined the association between combined oral contraceptive use and the risk of developing uterine fibroids in African-American women. The study followed fibroid-free participants and used ultrasound imaging to distinguish between incident and prevalent fibroids. The findings showed an inverse association between ever use of combined oral contraceptives and cumulative fibroid incidence. However, no consistent patterns were observed for the duration of or years since last combined oral contraceptive use. This research provides valuable insights into the relationship between contraception and uterine fibroids in African-American women. [Extracted from the article]

A recent study conducted by researchers at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, examined the effects of different forms of hormonal contraception on fatigue and recovery during exercise. The study involved 60 healthy, active women who were either using oral contraceptives, hormonal intrauterine devices, or had regular menstrual cycles. The researchers found that hormonal contraception and hormone phases had minimal impact on fatigue and recovery. However, they noted that elite female athletes may benefit from understanding how different types of hormonal contraception can slightly affect performance and recovery throughout the menstrual cycle. [Extracted from the article]

A preprint abstract from Women's Health Weekly discusses the potential effects of long-term combined oral contraceptive (COC) use on verbal and spatial performance. The study found that there were no significant differences in mental rotation, navigation, or verbal fluency performance between the active pill intake phase and the pill pause phase in long-term COC users. However, androgenic COC-users demonstrated faster navigation speed and higher orientation accuracy compared to anti-androgenic COC-users and non-users. The duration of COC use was associated with better orientation accuracy and decreased phonemic switching production. The study suggests that long-term COC use may have organizational effects on spatial and verbal processing. Please note that this preprint has not been peer-reviewed. [Extracted from the article]

A study conducted by researchers at King's College London aimed to understand the interaction between oral contraceptive use and rheumatoid arthritis (RA) in relation to the risk of venous thromboembolism (VTE). The study analyzed data from a large population-based sample of female adults in the United Kingdom. The results showed that women with RA had a higher risk of VTE compared to unaffected controls, regardless of their use of oral contraceptives or hormone replacement therapy. The study suggests that routine VTE risk assessments should be conducted for all females with RA. [Extracted from the article]

A new report from researchers at Federal University Mato Grosso in Brazil explores the effects of oral contraceptives (OC) on body composition in young women after resistance training. The systematic review analyzed seven studies and found that non-OC users experienced increased lean mass and thickness of type II muscle fibers, as well as reduced body fat, after resistance training. However, the effects of OC on body composition were less clear, with one study showing an increase in type I fiber cross-sectional area in the OC group and two studies finding no significant differences between groups. The researchers caution that minimal changes in body composition may impact performance, particularly for female athletes. [Extracted from the article]

A study conducted by the University of Southern California found that women living in states with the most restrictive abortion policies experienced declines in the use of birth control pills and emergency contraceptives after the Supreme Court's reversal of Roe v Wade. The study analyzed the impact of the Dobbs v. Jackson Women's Health Organization case and found that states that implemented a full ban on abortion saw significant reductions in the number of prescriptions filled for contraceptives. The closure of family planning clinics that provided abortion services may have contributed to the decrease in access to contraceptives. The study highlights the need for efforts to protect and improve access to oral and emergency contraceptives, especially in states where abortion is no longer an option. [Extracted from the article]

A clinical trial, NCT06461039, is being conducted by Novo Nordisk in Canada to investigate the effect of the compound NNC0487-0111 on the pharmacokinetics of an oral combination contraceptive and gastric emptying in females who cannot become pregnant. The purpose of the study is to determine if NNC0487-0111 affects the effectiveness of birth control pills. Female participants between the ages of 18 and 65 with a BMI between 25.0 and 39.9 kg/m^2 will take the study medicine orally for 18 weeks and then receive injections for 9 weeks. The trial is expected to last approximately 35 weeks and is estimated to be completed by April 7, 2025. [Extracted from the article]

A study investigated the impact of menstrual cycle phase and oral contraceptive use on neuromuscular impairments and the magnitude of the repeated bout effect (RBE) following eccentric exercise. Thirteen female participants performed two bouts of eccentric exercise four weeks apart. The study found that there was no difference in muscle weakness and soreness between normally menstruating females in the late follicular phase and females on oral contraceptives. The magnitude of the RBE was also similar between the two groups. This preprint has not been peer-reviewed. [Extracted from the article]

A recent study conducted at the University Medical Center Ljubljana in Slovenia examined the relationship between oral contraceptive (OC) use and the risk of developing endometriosis in women with primary infertility. The study found that previous OC use was higher in women with endometriosis compared to those without the condition. However, overall, previous OC usage was not significantly related to the diagnosis of endometriosis. The study did find that women who used OCs for less than 25% of their fertile age had a reduced risk of certain stages of endometriosis. Further research is needed to confirm these findings. [Extracted from the article]

This document provides information about a clinical trial for a topical gel called SM-030. The trial aims to evaluate the effectiveness and safety of two different concentrations of the gel in treating melasma, a skin condition characterized by hyperpigmentation. The trial is currently recruiting participants and is expected to be completed in July 2025. The eligibility criteria for participants are outlined, including age, skin type, and previous treatments. The document also includes administrative information such as the study ID number and the responsible party. [Extracted from the article]

This document provides information about a clinical trial, NCT06441747, that is investigating the potential benefits of combining durvalumab and olaparib in the maintenance treatment of patients with locally advanced or metastatic cholangiocarcinoma, a type of liver cancer. The trial aims to evaluate the efficacy, toxicity, progression-free survival, and overall survival of this combination therapy. It outlines the eligibility criteria for participants and provides administrative information about the trial, such as contact details and collaborators. The study is currently in the recruitment phase and is expected to start in August 2024, with an estimated completion date of August 2028. [Extracted from the article]

A patent application has been filed for an apparatus and method to induce human oocyte maturation in vitro. The invention aims to address challenges in maintaining oocyte health in culture, which can result in poor embryo quality. The apparatus includes a computing device and a memory with instructions to receive biological sample data, assign a stimulation protocol, receive culture data, and assign a scoring metric to the biological sample. The method involves receiving biological samples, assigning a stimulation protocol, culturing the samples, and assigning a scoring metric. The patent application provides detailed claims and descriptions of the invention. [Extracted from the article]

A recent study conducted by researchers from Ente Ospedaliero Cantonale explores the relationship between polycystic ovary syndrome (PCOS) and secondary aldosteronism. PCOS is a complex endocrine-metabolic disorder that affects approximately 7% of childbearing women and is characterized by anovulation, hyperandrogenism, and insulin resistance. The study found that patients with PCOS often exhibit high blood pressure and signs of hydro-saline retention. The researchers recommend performing hormonal screening for secondary hypertension in PCOS patients and conducting confirmatory tests to differentiate between primary and secondary forms of hyperaldosteronism. [Extracted from the article]

A recent study conducted by Neurocrine Biosciences Inc. investigated the effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam and ethinyl estradiol-levonorgestrel in healthy adults. The study found that NBI-1065845 did not induce the cytochrome P450 (CYP)3A enzyme and could be safely administered with CYP3A substrates. The drug was generally well-tolerated, with no new safety concerns observed. These findings provide valuable information for the development of NBI-1065845 as a potential treatment for major depressive disorder. [Extracted from the article]

A recent report from Shahed University in Tehran, Iran, compared the effects of Asafoetida, a traditional Persian medicine, with oral contraceptive tablets on patients with polycystic ovarian syndrome (PCOS). The study found that Asafoetida improved the occurrence of regular menstrual cycles and increased the incidence of pregnancy in PCOS patients. The researchers concluded that Asafoetida could be considered a safe treatment for patients with PCOS. This research provides new insights into the potential benefits of alternative treatments for female contraceptive agents. [Extracted from the article]

A recent study conducted by researchers at Western University of Health Sciences aimed to investigate the impact of social media on women's knowledge about oral contraception. The study surveyed over 2,000 English-speaking female followers of two popular platforms on Instagram and YouTube. The results showed that many participants held misconceptions about oral contraceptive use, with misinformation often originating from friends and social media sources. The researchers suggest that healthcare providers should be aware of the influence of online platforms on women's knowledge and use this information to improve counseling. [Extracted from the article]

A clinical trial, NCT06415279, is currently underway to assess the effectiveness of Clascoterone Cream 1% in reducing sebum production in acne patients. Acne is caused by the overproduction of sebum, which leads to bacterial growth. Clascoterone Cream 1% is believed to be a promising treatment for acne by reducing sebum production. The trial is open to individuals with mild to moderate acne and various skin types, and participants must agree to use only the study products for acne treatment. Certain medications and medical conditions may exclude individuals from participating. The study is being conducted by Sun Pharmaceutical Industries Limited. [Extracted from the article]

The National Taiwan University Hospital is conducting a clinical trial, NCT06409143, to investigate the effects of high-definition transcranial electrical stimulation (HD-tES) on upper extremity rehabilitation in patients with subacute stroke. HD-tES is a non-invasive treatment that modulates the excitability of the cerebral cortex using low direct current or alternating current. The trial aims to determine the optimal waveform and stimulation mode for stroke rehabilitation, comparing unilateral and bilateral stimulation. The study will assess motor function, sensory function, quality of life, and adverse events in participants. The trial is open to individuals with stroke and healthy individuals, and is expected to be completed by November 30, 2026. [Extracted from the article]

A recent study investigated the effects of oral contraceptives (OC) on approach and avoidance behavior in women, as well as the potential influence of stress. The study involved 130 female participants, half of whom were using OC and the other half were not using any hormonal contraception. The participants completed a task that measured automatic approach and avoidance behavior to socio-affective signals. The results showed that women using OC displayed reduced avoidance behavior to social threat signals and an increase in approach behavior to positive social signals after a stress manipulation. The study suggests that OC usage can impact social behavior, which may contribute to the development of affective side effects. However, there was no difference in cortisol stress response between the OC and non-contraceptive groups. [Extracted from the article]

A recent study conducted by the University of Kansas provides insights into polycystic ovary syndrome (PCOS), the most common endocrinopathy affecting women of childbearing age. The complex pathophysiology of PCOS involves genetic and environmental factors that contribute to insulin resistance. The diagnosis of PCOS is primarily clinical, based on the presence of specific criteria. PCOS is associated with various symptoms and complications, including hirsutism, acne, menstrual irregularities, dysglycemia, dyslipidemia, obesity, and an increased risk of cardiovascular disease and hormone-sensitive malignancies. Lifestyle modifications, such as caloric restriction and increased physical activity, form the foundation of therapy. Treatment options depend on the patient's desire for pregnancy, with oral contraceptives being the first-line therapy for patients who do not want to become pregnant. Letrozole is recommended for ovulation induction in patients who want to conceive, while metformin is used for patients with metabolic complications such as insulin resistance. Screening for depression and obstructive sleep apnea is recommended due to the increased risk in patients with PCOS. [Extracted from the article]

A clinical trial, NCT06402305, is currently recruiting participants to evaluate the lipid profile and ultrasound findings in patients with pancreaticobiliary diseases. The study aims to investigate the relationship between gall stones and multiple risk factors, including lifestyle factors, dietary factors, and serum lipids. It also examines the association between elevated serum triglyceride and low high-density lipoprotein cholesterol levels with persistent organ failure in acute pancreatitis. The study is being conducted in Egypt and is expected to be completed by May 2024. The primary contact for the study is Alaa M Mostafa from Sohag University. [Extracted from the article]

A report from Chouaib Doukkali University in Morocco discusses the bio-demographic characteristics of children with Down Syndrome (DS), their siblings, and their parents in the Moroccan population. The study conducted a retrospective survey between 2014 and 2017, collecting data from 277 families with 925 siblings and at least one child with DS. The analysis revealed that factors such as maternal age, paternal age, duration of exclusive breastfeeding, birth weight, and child age were associated with DS. The study also found higher levels of education, employment, and oral contraceptive use among women in the sample compared to national data. The researchers suggest that understanding the bio-demographic characteristics of individuals with DS can help families provide better care for this group. [Extracted from the article]